Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467857 · ClinicalTrials.gov registry record · Phase 4
Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination
A Phase 4 study, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 293
- Enrollment target
NCT00467857: Completed Phase 4 study, sponsored by Kimberly-Clark Corporation.
NCT00467857 is a Phase 4 study that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 293 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467857, a Phase 4 study, has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 293 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is a qualitative reduction in microbial skin flora post-surgery compared to pre-surgery when a cyanoacrylate based microbial sealant is used in combination with a surgical skin preparation solution.
Primary Outcome
Number of unique bacterial colony types isolated from samples of skin flora taken from the sternal incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.
Interventions
- PROCEDURE InteguSeal* skin sealant and standard surgical preparation
- OTHER Standard preoperative skin preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
What the finished NCT00467857 record still lists
NCT00467857 is an interventional study that assigns participants to a tested intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 2 interventions - of which InteguSeal* skin sealant and standard surgical preparation is the first listed.
NCT00467857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00467857 about?
NCT00467857 is a clinical study titled "Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination". The purpose of this study is to determine if there is a qualitative reduction in microbial skin flora post-surgery compared to pre-surgery when a cyanoacrylate based microbial sealant is used in combination with a surgical skin preparation solution.
What is the current status of trial NCT00467857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 293 participants. The study started on 2007-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00467857?
The interventions under investigation include: InteguSeal* skin sealant and standard surgical preparation (PROCEDURE), Standard preoperative skin preparation (OTHER).
Who is sponsoring clinical trial NCT00467857?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00467857's enrollment target sits among peer trials
293 296th of 2000 higher than 1,705 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia